In adult patients with nondysplastic Barrett esophagus at last endoscopy, a subsequent capsule-sponge test can assist in ...

CapsoVision announced today that it closed its initial public offering (IPO) and began trading on the Nasdaq Capital Market.

HealthDay News — In adult patients with nondysplastic Barrett esophagus at last endoscopy, a subsequent capsule-sponge test can assist in identifying those at highest risk of dysplasia or cancer ...

“Our findings suggest that the capsule sponge could help stratify patients with Barrett’s esophagus by risk and that half of ...

CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial intelligence ('AI”) technologies that are deployed in its capsule endoscopy ...

Over 22 thousand Americans face a chilling diagnosis. Early detection with a new three-minute test could change your chances ...

Mayo Clinic says that Lynch syndrome is caused by genes that are passed from parents to their children. I’ll let them explain: “Genes are pieces of DNA. DNA is like a set of instructions for every ...

On average 12% of Capsule Sponge positive patients would need to return for follow up endoscopy, equating to 17 patients with a total eCO2 output of 105.4kg CO2. The total kg CO2 calculation for ...

Multimodal AI chatbots assist gastroenterologists in real time, combining image, text, and context for smarter, faster ...

According to Research by SNS Insider, the Gastrointestinal Endoscopic Devices Market growth is Driven by Advancements in minimally invasive procedures and increasing prevalence of gastrointestinal ...